1.
Product Overview
2.
Research Methodology
3.
Impact of COVID-19 on Global Human Insulin Market
4. Executive Summary
5. Voice of Customer
6.
Global Human Insulin Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value &
Volume
6.2.
Market Share & Forecast
6.2.1. By Indication (Type
I Diabetes, Type II Diabetes)
6.2.2. By Brand (Lantus, Humulin
R, Novolin R, Humulin N, Exubera, Afrezza, Novolin N)
6.2.3. By Route of administration (Subcutaneous, Nasal, Intravenous, Transdermal, Oral and
Others)
6.2.4. By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional)
6.2.5. By Onset Time (Rapid Acting, Short-Acting, Intermediate Acting, Long Acting, Ultra-long Acting, Pre-Mixed, Inhaled)
6.2.6. By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection)
6.2.7. By Company (2019)
6.2.8. By Region
6.3. Market Attractiveness Index
7.
North America Human Insulin Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value &
Volume
7.2.
Market Share & Forecast
7.2.1. By Indication
7.2.2. By Brand
7.2.3. By Route of Administration
7.2.4. By Type
7.2.5. By Onset Time
7.2.6. By Products
7.2.7. By Country
7.3.
Market Attractiveness Index
7.4.
North America: Country Analysis
7.4.1. United States Human
Insulin Market Outlook
7.4.1.1.
Market Size & Forecast
7.4.1.1.1.
By Value
7.4.1.2.
Market Share & Forecast
7.4.1.2.1.
By Indication
7.4.1.2.2.
By Brand
7.4.1.2.3.
By Route of Administration
7.4.1.2.4.
By Type
7.4.1.2.5.
By Onset Time
7.4.1.2.6.
By Products
7.4.2. Canada Human Insulin
Market Outlook
7.4.2.1.
Market Size & Forecast
7.4.2.1.1.
By Value
7.4.2.2.
Market Share & Forecast
7.4.2.2.1.
By Indication
7.4.2.2.2.
By Brand
7.4.2.2.3.
By Route of Administration
7.4.2.2.4.
By Type
7.4.2.2.5.
By Onset Time
7.4.2.2.6.
By Products
7.4.3. Mexico Human Insulin
Market Outlook
7.4.3.1.
Market Size & Forecast
7.4.3.1.1.
By Value
7.4.3.2.
Market Share & Forecast
7.4.3.2.1.
By Indication
7.4.3.2.2.
By Brand
7.4.3.2.3.
By Route of Administration
7.4.3.2.4.
By Type
7.4.3.2.5.
By Onset Time
7.4.3.2.6.
By Products
8.
Europe Human Insulin Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value &
Volume
8.2.
Market Share & Forecast
8.2.1. By Indication
8.2.2. By Brand
8.2.3. By Route of Administration
8.2.4. By Type
8.2.5. By Onset Time
8.2.6. By Products
8.2.7. By Country
8.3.
Market Attractiveness Index
8.4.
Europe: Country Analysis
8.4.1. Germany Human
Insulin Market Outlook
8.4.1.1.
Market Size & Forecast
8.4.1.1.1.
By Value
8.4.1.2.
Market Share & Forecast
8.4.1.2.1.
By Indication
8.4.1.2.2.
By Brand
8.4.1.2.3.
By Route of Administration
8.4.1.2.4.
By Type
8.4.1.2.5.
By Onset Time
8.4.1.2.6.
By Products
8.4.2. United Kingdom Human
Insulin Market Outlook
8.4.2.1.
Market Size & Forecast
8.4.2.1.1.
By Value
8.4.2.2.
Market Share & Forecast
8.4.2.2.1.
By Indication
8.4.2.2.2.
By Brand
8.4.2.2.3.
By Route of Administration
8.4.2.2.4.
By Type
8.4.2.2.5.
By Onset Time
8.4.2.2.6.
By Products
8.4.3. France Human Insulin
Market Outlook
8.4.3.1.
Market Size & Forecast
8.4.3.1.1.
By Value
8.4.3.2.
Market Share & Forecast
8.4.3.2.1.
By Indication
8.4.3.2.2.
By Brand
8.4.3.2.3.
By Route of Administration
8.4.3.2.4.
By Type
8.4.3.2.5.
By Onset Time
8.4.3.2.6.
By Products
8.4.4. Italy Human Insulin
Market Outlook
8.4.4.1.
Market Size & Forecast
8.4.4.1.1.
By Value
8.4.4.2.
Market Share & Forecast
8.4.4.2.1.
By Indication
8.4.4.2.2.
By Brand
8.4.4.2.3.
By Route of Administration
8.4.4.2.4.
By Type
8.4.4.2.5.
By Onset Time
8.4.4.2.6.
By Products
8.4.5. Spain Human Insulin
Market Outlook
8.4.5.1.
Market Size & Forecast
8.4.5.1.1.
By Value
8.4.5.2.
Market Share & Forecast
8.4.5.2.1.
By Indication
8.4.5.2.2.
By Brand
8.4.5.2.3.
By Route of Administration
8.4.5.2.4.
By Type
8.4.5.2.5.
By Onset Time
8.4.5.2.6.
By Products
8.4.6. Russia Human Insulin
Market Outlook
8.4.6.1.
Market Size & Forecast
8.4.6.1.1.
By Value
8.4.6.2.
Market Share & Forecast
8.4.6.2.1.
By Indication
8.4.6.2.2.
By Brand
8.4.6.2.3.
By Route of Administration
8.4.6.2.4.
By Type
8.4.6.2.5.
By Onset Time
8.4.6.2.6.
By Products
9.
Asia-Pacific Human Insulin Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value &
Volume
9.2.
Market Share & Forecast
9.2.1. By Indication
9.2.2. By Brand
9.2.3. By Route of Administration
9.2.4. By Type
9.2.5. By Onset Time
9.2.6. By Products
9.2.7. By Country
9.3.
Market Attractiveness Index
9.4.
Asia-Pacific: Country Analysis
9.4.1. China Human Insulin
Market Outlook
9.4.1.1.
Market Size & Forecast
9.4.1.1.1.
By Value
9.4.1.2.
Market Share & Forecast
9.4.1.2.1.
By Indication
9.4.1.2.2.
By Brand
9.4.1.2.3.
By Route of Administration
9.4.1.2.4.
By Type
9.4.1.2.5.
By Onset Time
9.4.1.2.6.
By Products
9.4.2. India Human Insulin
Market Outlook
9.4.2.1.
Market Size & Forecast
9.4.2.1.1.
By Value
9.4.2.2.
Market Share & Forecast
9.4.2.2.1.
By Indication
9.4.2.2.2.
By Brand
9.4.2.2.3.
By Route of Administration
9.4.2.2.4.
By Type
9.4.2.2.5.
By Onset Time
9.4.2.2.6.
By Products
9.4.3. Japan Human Insulin
Market Outlook
9.4.3.1.
Market Size & Forecast
9.4.3.1.1.
By Value
9.4.3.2.
Market Share & Forecast
9.4.3.2.1.
By Indication
9.4.3.2.2.
By Brand
9.4.3.2.3.
By Route of Administration
9.4.3.2.4.
By Type
9.4.3.2.5.
By Onset Time
9.4.3.2.6.
By Products
9.4.4. South Korea Human Insulin
Market Outlook
9.4.4.1.
Market Size & Forecast
9.4.4.1.1.
By Value
9.4.4.2.
Market Share & Forecast
9.4.4.2.1.
By Indication
9.4.4.2.2.
By Brand
9.4.4.2.3.
By Route of Administration
9.4.4.2.4.
By Type
9.4.4.2.5.
By Onset Time
9.4.4.2.6.
By Products
9.4.5. Australia Human
Insulin Market Outlook
9.4.5.1.
Market Size & Forecast
9.4.5.1.1.
By Value
9.4.5.2.
Market Share & Forecast
9.4.5.2.1.
By Indication
9.4.5.2.2.
By Brand
9.4.5.2.3.
By Route of Administration
9.4.5.2.4.
By Type
9.4.5.2.5.
By Onset Time
9.4.5.2.6.
By Products
9.4.6. Singapore Human
Insulin Market Outlook
9.4.6.1.
Market Size & Forecast
9.4.6.1.1.
By Value
9.4.6.2.
Market Share & Forecast
9.4.6.2.1.
By Indication
9.4.6.2.2.
By Brand
9.4.6.2.3.
By Route of Administration
9.4.6.2.4.
By Type
9.4.6.2.5.
By Onset Time
9.4.6.2.6.
By Products
10.
South America Human Insulin Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value &
Volume
10.2.
Market Share & Forecast
10.2.1. By Indication
10.2.2. By Brand
10.2.3. By Route of Administration
10.2.4. By Type
10.2.5. By Onset Time
10.2.6. By Products
10.2.7. By Country
10.3.
Market Attractiveness Index
10.4.
South America: Country Analysis
10.4.1. Brazil Human Insulin
Market Outlook
10.4.1.1. Market Size & Forecast
10.4.1.1.1.
By Value
10.4.1.2. Market Share & Forecast
10.4.1.2.1.
By Indication
10.4.1.2.2.
By Brand
10.4.1.2.3.
By Route of Administration
10.4.1.2.4.
By Type
10.4.1.2.5.
By Onset Time
10.4.1.2.6.
By Products
10.4.2. Argentina Human
Insulin Market Outlook
10.4.2.1. Market Size & Forecast
10.4.2.1.1.
By Value
10.4.2.2. Market Share & Forecast
10.4.2.2.1.
By Indication
10.4.2.2.2.
By Brand
10.4.2.2.3.
By Route of Administration
10.4.2.2.4.
By Type
10.4.2.2.5.
By Onset Time
10.4.2.2.6.
By Products
10.4.3. Colombia Human
Insulin Market Outlook
10.4.3.1. Market Size & Forecast
10.4.3.1.1.
By Value
10.4.3.2. Market Share & Forecast
10.4.3.2.1.
By Indication
10.4.3.2.2.
By Brand
10.4.3.2.3.
By Route of Administration
10.4.3.2.4.
By Type
10.4.3.2.5.
By Onset Time
10.4.3.2.6.
By Products
11.
Middle East and Africa Human Insulin Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value &
Volume
11.2.
Market Share & Forecast
11.2.1. By Indication
11.2.2. By Brand
11.2.3. By Route of Administration
11.2.4. By Type
11.2.5. By Onset Time
11.2.6. By Products
11.2.7.